Interaction Checker
Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.
1 combination(s) marked "avoid": Halotestin + LGD-4033. Review these interactions carefully.
Elevated gonads load from Halotestin, LGD-4033. Monitor this organ system closely.
Elevated liver load from Halotestin, LGD-4033. Monitor this organ system closely.
Cumulative Organ Load
Gonads elevated
Liver elevated
Heart moderate
Shared Safety Flags
2x 2 androgenic compounds (Halotestin, LGD-4033). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds raise blood pressure (Halotestin, LGD-4033). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the carcinogenic-risk safety flag (Halotestin, LGD-4033). Monitor accordingly.
2x 2 hepatotoxic compounds (Halotestin, LGD-4033). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Halotestin, LGD-4033). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Halotestin, LGD-4033). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Halotestin, LGD-4033). Monitor accordingly.
Both Halotestin and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.